Invitation

SHEDDING LIGHT ON PHOTODYNAMIC THERAPY

– What is the balance between Patient Convenience and Treatment Efficacy?

Thuesday November 28th 17.00-18.30 CET – HYBRID.

Followed by country specific live discussions 18.30-19.30 CET

Invitation

SHEDDING LIGHT ON PHOTODYNAMIC THERAPY

– What is the balance between Patient Convenience and Treatment Efficacy?

Thuesday November 28th 17.00-18.30 CET – HYBRID.

Followed by country specific live discussions 18.30-19.30 CET

Content and Objectives

This hybrid Pan-Nordic medical education will give an overview of Photodynamic Therapy (PDT) and its place in the treatment of Actinic Keratosis and Basal Cell Carcinoma.  The event will cover the history of Photodynamic Therapy, mode of action and also the advantages and disadvantages of PDT compared to other treatment regimens and will try to answer the following questions: Who are suitable patients for PDT? And how to handle the most common practical issues?

There are two possibilities to attend this meeting, either via MS TEAMS or together with colleagues at different location around the Nordic Countries for summarizing discussions, enjoy a light meal and sharing best practices.

We are happy to take relevant questions before the meeting via a link to a survey in the confirmation email you get after registration.

Target Audience

Dermatologists in private and hospital practice (also residents)

Dermatology and PDT nurses.

Practical Information Live streaming

Date: 28th of November 2023

Time: 17.00 – 18.30 Central European Time

Platform: Microsoft Teams

Cost

This meeting is free of charge. Galenica finance speaker cost, meal and meeting rooms. Participants cover their own travel cost.

Approval of attendance

The participant must obtain permission from their employer to attend the meeting according to country specific rules and regulations.

This event will be reported to ENLI, LIF.

Locations Agenda

Copenhagen – Scandic Spectrum

Kalvebod Brygge 10, København V

Program

16.30 Gathering and light meal

17.00 -18.30 Webinar streaming starts

18.30 – 19.30 Country specific discussions about webinar

Stockholm 

Clarion Hotel Sign, Östra Järnvägsgatan 35, Stockholm

Program

16.30 Gathering and light meal

17.00 -18.30 Webinar streaming starts

18.30 – 19.30 Country specific discussions about webinar

Malmö 

Galenica Office, Medeon Science Park, P A Hanssons Väg 41, Malmö,

Program

16.30 Gathering and light meal

17.00 -18.30 Webinar streaming starts

18.30 – 19.30 Country specific discussions about webinar

Oslo 

Clarion Collection Hotel Gabelshus, Gabelsgt 16, Oslo

Program

16.30 Gathering and light meal

17.00 -18.30 Webinar streaming starts

18.30 – 19.30 Country specific discussions about webinar

Helsinki 

Scandic Grand Central, Vilhonkatu 13, Helsinki

Program (local time)

17.30 Gathering and light meal

18.00 -19.30 Webinar streaming starts

19.30 -20.30 Country specific discussions about webinar

PDT-Nordic-0012-230807

Speaker:
Dr.Med. Stine Regin Wiegell

Stine Regin Wiegell has a PhD in Photodynamic therapy from the University of Copenhagen. She has published multiple papers on photodynamic therapy and  together with Professor Hans Christian Wulf developed the concept of daylight-mediated photodynamic therapy. She is associated professor at the University of Copenhagen and a consultant at the department of Dermatology, Bispebjerg University Hospital Copenhagen. At the hospital Stine is responsible for the Phototherapy department treating non-melanoma skin cancer and photodamaged skin and also inflammatory skin diseases.

Register here!

I register for (only one item) *

I have read and understood Galenica AB´s Privacy Policy and I consent that Galenica AB process my personal data and to receive communications from Galenica AB on products, services, as well as medical and scientific information. My personal data is protected and processed in accordance with GDPR and Galenicas Privacy Policy. I can unsubscribe at any time by clicking the unsubscribe link included in future email communications sent to me.